HMN 2025: How Disturbed dopamine signaling pathways may promote epileptic seizures in focal cortical dysplasia

Focal cortical dysplasia (FCD) kind 2 is a congenital malformation of the cerebral cortex that’s typically related to difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer constructions are organized in an atypical method, which regularly makes drug remedy tougher.

A analysis crew from the University Hospital Bonn (UKB) and the University of Bonn, in collaboration with the German Center for Neurodegenerative Diseases (DZNE), has now discovered proof of profound modifications within the dopamine system in FCD kind 2. The outcomes have now been published within the journal Brain.

Dopamine is a central neurotransmitter that regulates consideration, {learning} and the excitability of neuronal networks, amongst different issues. Whether and the way this method is affected by FCD has up to now remained largely unclear. The present study exhibits that the dopaminergic provide within the affected mind areas is altered. In addition, an elevated expression of sure dopamine receptors was noticed—each in human tissue and in a corresponding mouse model.

Evidence of disturbed modulation within the creating cortex

“Our information recommend a disrupted dopaminergic system in FCD kind 2,” explains Norisa Meli, a doctoral scholar on the University of Bonn on the Institute for Reconstructive Neurobiology on the UKB and first writer of the research. “Particularly hanging was the considerably elevated expression of dopaminergic receptors within the neurons that play a central position within the illness course of.”

These modifications may play a task within the improvement of epileptic seizures—and presumably additionally clarify why many victims additionally {experience} focus issues or temper swings.

“Dopamine modulates the excitability of neuronal networks and their formation within the creating cortex,” emphasizes Prof. Sandra Blaess, Professor of Neurodevelopment at UKB and member of the TRA “Life & Health” on the University of Bonn. “Our outcomes present that this modulation could also be disturbed in FCD kind 2—a facet that has hardly been investigated so far.”

Prof. Albert Becker, Head of Department on the Institute for Cellular Neuroscience II on the UKB and in addition a member of the TRA “Life & Health” on the University of Bonn, provides, “These findings broaden our understanding of the complicated neuropathology of dysplasias. They present vital clues for brand spanking new potential therapeutic approaches that would transcend the mere {control} of seizures.”

The study combines complete molecular analyses of human tissue samples with a preclinical mouse model that replicates the genetic modifications in FCD kind 2. The researchers hope that these outcomes will contribute to extra focused and efficient therapy methods in the long run.